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Antibiotics are the chemotherapeutic agents that kill or inhibit the pathogenic microorganisms. Re-
sistance of microorganism to antibiotics is a growing problem around the world due to indiscriminate
and irrational use of antibiotics. In order to overcome the resistance problem and to safely use antibiotics,
the correct measurement of potency and bioactivity of antibiotics is essential. Microbiological assay and
high performance liquid chromatography (HPLC) method are used to quantify the potency of antibiotics.
HPLC method is commonly used for the quantiﬁcation of potency of antibiotics, but unable to determine
the bioactivity; whereas microbiological assay estimates both potency and bioactivity of antibiotics.
Additionally, bioassay is used to estimate the effective dose against antibiotic resistant microbes.
Simultaneously, microbiological assay addresses the several parameters such as minimal inhibitory
concentration (MIC), minimum bactericidal concentration (MBC), mutation prevention concentration
(MPC) and critical concentration (Ccr) which are used to describe the potency in a more informative way.
Microbiological assay is a simple, sensitive, precise and cost effective method which gives reproducible
results similar to HPLC. However, the HPLC cannot be a complete substitute for microbiological assay and
both methods have their own signiﬁcance to obtain more realistic and precise results.
& 2016 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. This is an open access article
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Antibiotics are the chemotherapeutic agents that kill or inhibit
the growth of microorganisms. These chemical agents are used to
treat disease by destroying pathogenic microorganisms oron and hosting by Elsevier B.V. Th
University.
al Engineering Research In-inhibiting their growth at concentration low enough to avoid
undesirable damage to the host. Antibiotics are drugs preparations
which contain some chemical substances that are produced by
microorganisms and by chemical synthesis. These substances at
very low concentrations are known to totally destroy or partially
inhibit microorganisms [1,2]. Antibiotics have widespread appli-
cation in the treatment of bacterial disease [3].
Antimicrobial chemotherapy plays a critical role in ﬁghting
against infectious disease caused by microorganisms but antibiotic
resistant microorganisms are an increasing problem of public
health. The misuse of antibiotics fosters the increase and spread ofis is an open access article under the CC BY-NC-ND license
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increasing resistant problems, the quantiﬁcation of the actual
concentration of active ingredient in antibiotic preparation is
critical.
The effectiveness of antibiotic agents depends on many factors
such as route of administration, location of infection, presence of
interfering substances, concentration of the drug in the body,
nature of the pathogen, presence of drug allergies and resistance
of microorganism to the drug [5]. The effectiveness of antibiotics is
described in terms of potency and accurate measurement of po-
tency is critical in pharmacology to safe and proper use of anti-
biotics [6].
Antibiotics are considered most commonly faked and adulter-
ated pharmaceutical products [7]. A mild difference in the con-
centration of active ingredient in antibiotic preparations may have
impact in actual efﬁcacy. Therefore, quantiﬁcation of active phar-
maceutical ingredient (API) in antibiotic preparation is very ne-
cessary [4,8]. The quantiﬁcation of active ingredient is critical for
drug regulatory agencies around the world [9]. The quantiﬁcation
of active ingredient in antibiotic preparations is important to ob-
tain the same pharmaceutical equivalence of generics as compared
to innovate products.
The potency of antibiotics can be determined by chemical and
biological methods [4]. These methods include microbiological
assays, automated chemical assays (e.g. high performance liquid
chromatography (HPLC)), immunological assays (e.g. ﬂuorescence
polarization immune assay, ﬂuorescence immunoassay) and
radioimmunoassay [10]. However, the assay methodology has
changed to chromatographic assays for many antibiotics as they
provide quantitative measurements of the purity and the amounts
and types of impurities in antibiotics. Nevertheless, a number of
commercially important antibiotics continue to require potency
determination by microbiological assays [11]. The measurement of
antibiotic components is generally done by chemical methods
such as HPLC and UV spectrophotometry, but these methods
cannot provide a true indication of biological activity which is the
main limitation of these methods. However, microbiological assay
can precisely determine both potency and bioactivity of an anti-
biotic. Besides, microbiological assay does not require specialized
equipment or toxic solvents [12,13]. Impurities and related sub-
stances do not affect the results of microbiological assay [14]. It
also precisely quantiﬁes the actual concentration of active in-
gredient in antibiotic preparation when microbial resistant pro-
blem arises. Microbiological method is the most convenient way to
determine the potency of antibiotics [15].
A reduction in antimicrobial activity will also reveal subtle
changes not demonstrable by chemical methods [16,17]. The mi-
crobiological assay is the only standard method for the estimation
of loss in the activity of an antibiotic [17]. The inhibition of mi-
crobial growth in standardized conditions may be utilized in de-
monstrating the therapeutic efﬁcacy of antibiotics. However, the
effective and fully characterized microbial strain is required for
microbiological assay. The identiﬁcation and characterization of
microbial strain are performed by cultural and non-cultural tech-
niques [18,19].
Determination of antimicrobial potency is extremely important
for the quality control and quality assurance of antibiotic pre-
parations. Hence, it is necessary to select practical and economical
method for quality control of antibiotics [20,21]. Recently an ap-
plication of microbiological assay has been developed for in-
travenously administered antibiotics. This method is highly ac-
ceptable by regulating authorities to control antibiotic potency [9].
Being a biological assay, microbiological assay is subject to some
biological errors, but after validating all variable parameters it is
possible to obtain meaningful results and to achieve a precision
similar to that of many chemical methods [14]. Microbiologicalassay in comparison to chemical methods measures the true re-
sponse of antibiotics on biological system and is used to obtain
more realistic and precise measurement of potency to overcome
the antibiotic resistance problem [4].2. Microbiological assay methods
Microbiological assays are prescribed for the drug substances
and preparations where the potency cannot be adequately de-
termined by chemical means. Additionally, the resistance and
sensitivity of pathogenic microorganisms is also determined by
microbiological assays. These are performed daily on bacterial
isolates in clinical and quality control laboratories. All micro-
biological assay techniques involve either diffusion of anti-
microbial agent in the agar or dilution of antibiotic in agar or
broth. Different designs of microbiological assay are available for
the estimation of potency, bioactivity and resistance of antibiotics.
Kirby-Bauer disk diffusion method is used to determine the
sensitivity or resistance of pathogenic aerobic and facultative
anaerobic bacteria to various antimicrobial compounds. The pa-
thogenic microorganism is grown on Mueller-Hinton agar in the
presence of various antimicrobial impregnated ﬁlter paper disks.
The absence of microbial growth around the disks indicates the
ability of that antimicrobial compound to inhibit the growth of
microorganism [5]. The broth dilution method involves subjecting
the isolate to a series of concentrations of antimicrobial agents in a
broth environment. Microdilution testing uses about 0.05–0.1 mL
total broth volume and can be conveniently performed in a Mi-
crotiter plate. Macrodilution testing uses broth volumes at about
1.0 mL in standard test tubes. For both of these broth dilution
methods, the lowest concentration at which the isolate is com-
pletely inhibited is recorded as minimal inhibitory concentration
(MIC). In agar dilution method an antimicrobial agent is in-
corporated into a solid agar medium in a Petri dish. A standard
concentration of organisms is inoculated onto the surface of this
medium. No growth of the test organism after incubation indicates
that it is susceptible at the antimicrobial concentration in-
corporated into the medium [5]. The agar dilution method pro-
vides a speciﬁc MIC of an antimicrobial agent.
E-test (Epsilometer test) is a quantitative method for anti-
microbial susceptibility testing. In E-test, a thin inert carrier strip
having antimicrobial agent is applied onto an inoculated agar
plate. After incubation, the asymmetrical inhibition ellipse is
produced. The intersection of the inhibitory zone edge and the
calibrated carrier strip indicates the MIC value over a wide con-
centration range (410 dilutions) with inherent precision and ac-
curacy [22].
The agar diffusion method (Cylindrical-plate or Cup-plate) is a
most widely employed method for the estimation of potency and
bioactivity of antibiotics. The agar diffusion method depends on
diffusion of the antibiotic from a vertical cylinder through a soli-
diﬁed agar layer in a Petri dish. The growth of the speciﬁc mi-
croorganisms inoculated into the agar is prevented in a circular
area or zone around the cylinder containing the antibiotics [23,24].
The principle of such assay is to compare how much of a sample
under examination produces the similar biological effect as in a
given quantity of a standard preparation [17,23,24]. The agar dif-
fusion method relates the size of the inhibition zone and the dose
of the antibiotic assayed. The relation of the diameter of inhibitory
zones and the concentration of antibiotic in a solution applied in
cups has been considered theoretically [1].
3. Different assay designs for agar diffusion assay
Different pharmacopoeias recommended different designs of
Table 1
Different bioassay designs for agar diffusion assay.
Assay design Dose ratio Pharmacopoeia Informative statistical parameters References
22 2:1, 4:1 Indian Pharmacopoeia, British Pharmacopoeia, Brazilian Pharmacopoeia Regression signiﬁcance, Parallelism [21]
33 2:1 Indian Pharmacopoeia, British Pharmacopoeia, Brazilian Pharmacopoeia Regression signiﬁcance, Parallelism [28]
31 2:1 European Pharmacopoeia Regression signiﬁcance, Linearity [21]
51 4:5 Indian Pharmacopoeia, United States Pharmacopoeia Regression signiﬁcance, Linearity [21,27]
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ted by Indian Pharmacopoeia [23], British Pharmacopoeia [24] and
Brazilian Pharmacopoeia [25]. The 51 assay design is adopted by
Indian Pharmacopoeia [23] and United States Pharmacopoeia [17]
whereas 31 assay design is adopted by the European Pharma-
copoeia. The use of an adequate experimental design in relation to
the criteria of linearity, precision and accuracy of the analytical
results are fundamental requirement. It is highly advisable to
adopt an assay design which, without further effort, gives better
results. The number and nature of the samples are the most im-
portant factors to be taken into account, in the selection of a de-
sign [21].
The 22 assay design also known as symmetrical and ba-
lanced assay is simple and effective which employs two doses of
standard and two doses of sample with the same concentration.
Each Petri dish includes four doses of both preparations in an al-
ternative manner and in such a way that the number of replicates
equals that of dishes (Fig. 1A) [21]. In 33 assay design three dose
levels of each standard and sample are used as shown in Fig. 1B.
Six dishes were employed for each sample assayed through 33
experimental design [26]. The 51 assay includes ﬁve prepara-
tions of standard and one preparation of sample which is equal to
the median standard concentration. In 51 assay design, ﬁve Petri
dishes were used for each assay in order to test the reference
concentration concomitantly with each standard or sample con-
centration (Fig. 1C) [1,27].
In 31 assay design, three preparations of standard and one
preparation of sample equal to the median standard concentration
are used. Six dishes were employed for each sample assayed
through 31 experimental designs [12].
Different designs are recommended for different purposes
considering cost, errors, and simplicity of the assay. The 22 andFig. 1. Assay designs for agar diffusion bioassay: (A) 22 bioassay; (B) 3333 assays are recommendable for research and development, as
they give information about the regression signiﬁcance and par-
allelism between the standard curve and the sample that permits
the evaluation of the test validity. The 51 assay is proved to be
appropriate for routine analysis in quality control laboratories
where a high number of samples can be evaluated simultaneously.
The 31 assay is adequate for routine analysis in quality control
laboratories, as it simpliﬁes the test execution and the potency
calculation, besides offering advantages in terms of low cost and
the material involved. As per different pharmacopoeias, different
assay designs and their recommended dose ratios are mentioned
in Table 1.
22, 31 and 51 assay designs were compared for genta-
mycin. The statistical analysis demonstrated that there was no
signiﬁcant difference between the results obtained through 22,
31 and 51 assays and they were equivalent and inter-
changeable [21].4. Parameters used to deﬁne potency of antibiotics
Potency measurements by microbiological assays are more in-
formative in comparison to HPLC and provide true information
about the bioactivity of a given antibiotic. Several in vitro para-
meters can be used to determine the potency of antibiotics, in-
cluding MIC, minimum bactericidal concentration (MBC), muta-
tion prevention concentration (MPC) and critical concentration
(Ccr).
MIC is considered as the standard parameter to determine the
susceptibility of microorganism to antimicrobial agents. MIC can
be deﬁned as the lowest concentration of an antimicrobial agent
that can inhibit the visible growth of microorganisms afterbioassay; and (C) 51 bioassay. S: standard solutions; T: test solutions.
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Fig. 2. Pharmacodynamic depiction of the mutant selection window.
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termine the in vitro activity of new antimicrobial agents and from
such studies important data can be obtained to determine MIC
breakpoints [30]. MIC is also used in diagnostic laboratories to
conﬁrm unusual resistance [31,32], to compare the in vitro activity
of different antimicrobial agents [33,34], to assess the in vitro
activity of antibiotic combinations against resistant organism [35]
and to give dose recommendations of antibiotics [36]. MIC values
indicate antibiotic potency and can only be compared within the
respective classes of antibiotics. When comparing antibiotics that
have the same molecular class and mode of eradication, the anti-
biotic with the lowest MIC is more potent because less antibiotic is
required to eradicate the bacteria. Several methods such as broth
dilution method [35], agar dilution method [37] and agar diffusion
method [38] have been used to calculate MIC.
MBC is recognized as the standard quantitative index of the
bactericidal potency of antimicrobial agents. MBC is deﬁned as the
lowest concentration of antimicrobial agent that prevents the
growth of a microorganism after subculturing to an antibiotic free
medium [39]. MBC values reﬂect the antibiotic concentration at
which 99.9% eradication of bacterial isolates occurs. MBC can be
determined by broth dilution methods combined with agar plate
methods. The bactericidal activity of antibiotic is an important
parameter for pathogen eradication; and the more potent is an
antimicrobial agent, the less likely is resistant selection [40]. MIC
and MBC values are similar for bactericidal agents that kill bac-
teria. MBC values provide less information when applied to bac-
teriostatic agents that inhibit bacterial growth such as macrolides.
MPC is the antibiotic concentration that allows no mutant to
grow [41], or a concentration above which bacterial cells require
the presence of two or more resistant mutants for growth [42].
MPC is a new concept applied to face the increased prevalence of
antibiotic resistance problems by using antibiotic concentration
that can prevent the selection of resistant mutants [43]. MPC va-
lues represent the antibiotic concentration at which 100% eradi-
cation of isolates occurs. MPC can be applied to calculate potency
of antibiotics, to compare the efﬁcacy of different antibiotics
against single step resistant mutants and to compare the incidence
of resistant mutant occurrence [44]. Due to the increasing re-
sistance problem of antibiotics for many infectious diseases, it is
necessary to prevent further selection of resistant mutants so that
a concentration of antibiotic can be attained at which no mutant is
recovered even when 1010 to 1011 cells are plated [45]. For tech-
nical convenience and comparative purpose MPC is deﬁned as the
concentration at which no colony recovery was observed when
Z1010 cells are applied. MPC can be determined by the same agar
dilution method used for determination of MIC and more (1010)
cells are required for MPC determination [43]. MPC has been used
to examine the ﬂuoroquinolone potency against clinical isolates of
Mycobacterium tuberculosis [42] and Streptococcus pneumonia [46].
MPC testing gives a theoretical proﬁle of antimicrobial character-
istics, but has not been proven reliable in animal studies or clinical
trials. An antibiotic concentration window exists in which resistantmutants are selectively ampliﬁed. The upper boundary of the
window is an antibiotic concentration that blocks the growth of
least susceptible, ﬁrst-step resistant mutants. The lower boundary
is the lowest antibiotic concentration that blocks the growth of the
majority of antibiotic susceptible cells. Because the upper and
lower limits of the window are measurable, antibiotics can be
compared to ﬁnd compounds that have narrower windows and
that are best suited for administration above the upper boundary
(Fig. 2).
Ccr is the minimal concentration of antibiotic that inhibits
microorganism growth and prevent bacterial concentration to
reach critical point [38]. Antibiotic activity can be expressed in
terms of Ccr which is a parameter of the microorganism's sensi-
tivity under particular assay condition [39]. Ccr can be two to four
times greater than the MIC, which is determined under different
conditions [47].5. Factors inﬂuencing variability and error in microbiological
assays
Microbiological assay provides a valid measure of antibiotic
activity with some problem of interference from biologically active
compounds or degraded products [28]. Several factors are in-
vestigated by scientists that normally cause variation in zone
diameters in conventional agar diffusion bioassay. Among these
factors the most considerable factor is the unequal exposure of the
individual plates at the top or bottom of the stacks. Another major
variable is the variable in the time interval between pouring see-
ded agar in the plates and the time of applying the solution of the
antibiotic to the plates [48].
Other factors that lead to variability and error in micro-
biological assay include agar thickness, inoculums concentration,
incubation temperature, exposure-time duration and sample pre-
paration. Factors affecting microbial growth rates include pH and
chemical composition of media and pH of buffer solution used. The
effects of different pHs of buffer on the growth of different mi-
crobial strains were observed [1,4]. The thickness of the agar layer
greatly affects the resulting zone diameter. The higher the thick-
ness of agar layers, the smaller the zone diameter. Similarly, an
inﬂuence of inoculums concentration on resulting zone size is
widely recognized [1,4,14]. Experiments were performed to de-
termine how critical the concentration of inoculums might be,
when other factors are constant [1,4]. High inoculum concentra-
tion of test microorganism shows hazy growth appearance on the
medium plate and no appearance of antimicrobial activity of an-
tibiotic, whereas low concentration of inoculum shows light and
immeasurable zone.
Variation in incubation temperature of plates in different po-
sitions within stacks (i.e., top and bottom) is unavoidable but can
be minimized by enclosure of stacks in close-ﬁtting steel cylinders
and avoidance of large temperature shifts, particularly between
room and incubator temperature. Chemical composition of the
media can be ﬁxed and optimized that favors rapid growth of
microorganism. pH of media can be adjusted initially and main-
tained by the addition of hydrochloric acid or sodium hydroxide in
sufﬁcient quantities. The maintenance of pH of media is an es-
sential step because the growth of indicator microorganism can
lead to change in pH of media. It was observed that germination of
Bacillus subtilis spores led to an upward shift in pH [49].
Experimental variability in microbiological assay can be mini-
mized by improved handling, using multiple disks or cylinders on
the same Petri dish to eliminate the differential effects from
growth, time and temperature by reducing the wedge effect.
Variability of microbiological assays can also be minimized by
incorporation of external reference plates at spiced locations and
Table 2
Correlation between HPLC and agar diffusion bioassay.
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bioassay has a capability to give high level of reproducibility and
precision.Antibiotic Correlation coefﬁcient (R) Medium References
Clarithromysin 0.871 Serum [51]
Cefoparazone Z0.95 Serum [61]
Cefoxitin Z0.95 Serum [61]
Oﬂoxacin 0.845 Serum [52]
Fluconazole 0.988 In vitro [27]
Cefuroxime 0.991 Plasma [62]
Vancomysin 0.975 Plasma [10]
Amoxicillin capsule 0.996 Plasma [63]
Amoxicillin injection 0.997 Plasma [63]
Amoxicillin granule 0.998 Plasma [63]6. Quantiﬁcation of antibiotics by HPLC method
HPLC is a chromatographic technique used for the identiﬁca-
tion, quantiﬁcation and puriﬁcation of individual components of a
mixture in analytical chemistry [50]. HPLC is used extensively
throughout the pharmaceutical industries for the quantiﬁcation of
antibiotics in pharmaceutical preparations. It is used to provide
information on the composition of drug related samples. The in-
formation obtained may be qualitative, indicating what com-
pounds are present in the sample, or quantitative, providing the
actual amounts of compounds in the sample [50]. HPLC is used at
all the different stages in the creation of a new drug, and is also
used routinely during drug manufacturing. It is more attractive
than the classical bioassay in terms of speed, accuracy and preci-
sion. Hence, it has largely replaced the microbiological assays to
determine the antibiotic concentrations in body ﬂuids and phar-
maceutical preparations [9].7. Comparison of microbiological assay and HPLC method
When comparing the microbiological assay and chemical assay,
each exhibits several advantages and deﬁciencies [51]. Both mi-
crobiological and HPLC methods are used to evaluate the potency
of antibiotics [26,27] and to determine drug concentration in body
ﬂuids [52] and in therapeutic drug monitoring [53].
Microbiological assay methods are one of the most widely ac-
cepted methods for determination of antibiotic potency. However,
in spite of some advantages of HPLC method, microbiological assay
because of its simplicity, accuracy and inexpensiveness is still re-
commended as a method of choice in routine potency measure-
ment when immediate results are not required and therapeutic
regimes are known [51,54,55]. Validated chemical methods are
also considered speciﬁc and accurate, but these tests are likely to
be very narrow in their application and much more difﬁcult to
establish than microbiological test. Although automated chemical
methods are more attractive than the classical bioassay in terms of
speed, accuracy and precision [56] and have largely replaced the
microbiological assays to determine the antibiotic concentrations
in body ﬂuids (serum, plasma or urine) [9,53,57], these methods
have limitations when a drug resistance against a particular anti-
biotic arises.
Potency estimation of antimicrobial agent by using a micro-
biological assay is based on its inhibitory effect on microorganism
under suitable conditions. Moreover, in contrast to microbiological
assays, chemical assays require expensive instrumentation and are
time-consuming [58]. A validated bioassay that can be used ac-
curately and in a reproducible manner is suitable for both research
and pharmaceutical industry. Microbiological assay plays an es-
sential role in manufacturing and quality control of antibiotic
medicines [14,59].
However, automated assays and bioassays are frequently used
and accepted by generic manufacturers as interchangeable and
complementary of the other methods [17,60]. Microbiological and
chemical assays were compared to measure drug concentration in
body ﬂuid and both the assays performed equally well with a
minor difference in the results [52]. Microbiological assays were
found to determine higher contents of API as compared to HPLC
[52,56]. Different antibiotic concentrations in body ﬂuids and in
vitro potencies of different antibiotics by means of both assays
were compared and a strong correlation was found, whichreﬂected the accuracy of microbiological assay in comparison to
HPLC (Table 2).
Antimicrobial activity of degraded antibiotic such as ﬂuor-
oquinolone can be determined by microbiological assay and their
presence can be conﬁrmed in parallel by HPLC [64]. HPLC is used
to determine the potency of antibiotics, but that is not an actual
measurement of potency [59]. On the other hand, microbiological
assay using a living system gives a more realistic measurement of
antibiotic potency. A reduction in antimicrobial activity due to
slight changes in antibiotic structure can be only detected by mi-
crobiological assay. Moreover, using a microbiological assay to
measure antibiotic potency is more informative and also gives an
idea about susceptibility proﬁle of pathogenic organism to that
antibiotic [65].
Articles show that microbiological assay can be used with al-
most the same accuracy to determine the potency of antibiotics
with HPLC. M.C. Hsu and P.W. Hsu [63] compared the percent
potency of amoxicillin in capsule, injection and granule formula-
tions by microbiological assay and HPLC method. No signiﬁcant
difference in the assay values was obtained by these two methods.
The correlation coefﬁcients were found to be 0.996 for capsule,
0.997 for injection, and 0.998 for granule dosage forms. The po-
tency of amoxicillin injection obtained by microbiological assay
and HPLC method is shown in Fig. 3. Results showed a strong
correlation between both the methods [63]. When a graph was
plotted between the potency estimated by both the methods, a
good linearity was obtained (Fig. 3 inset).8. Conclusion
Antibiotics are a type of antimicrobial agents used in the
treatment and prevention of bacterial infection. The resistance of
microorganism to antibiotics is one of the most serious problems
around the world. To overcome the resistance problem and to
safely use antibiotics, the correct measurement of potency and
bioactivity of antibiotics is essential. Generally microbiological
assay and HPLC method are used to measure the potency of an-
tibiotics, but still there is controversy regarding the selection of an
appropriate method among the researchers and pharmaceutical
industries. The literature ﬁnding shows that both microbiological
assay and HPLC method exhibit several advantages and in-
adequacies. Although HPLC method is fast, accurate and precise for
quantiﬁcation of potency of antibiotics, it can not determine
bioactivity. However, microbiological assay is simple, sensitive,
accurate, precise and cost effective to estimate both potency and
bioactivity. Besides this, microbiological assay become the most
important method to quantify the concentration of active in-
gredient required for the inhibition of growth of antibiotic
Fig. 3. Comparison of the potency of amoxicillin injection determined by microbiological assay and HPLC method. Inset: The linearity of microbiological assay and HPLC
method.
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Microbiological assay has some biological errors, but after va-
lidating all variable parameters it is possible to achieve a precision
similar to that of HPLC method. A validated microbiological assay
can give signiﬁcant results and is suitable for research and phar-
maceutical industries. As HPLC is an automated fast and accurate
method for the estimation of the potency of antibiotic, it is used
for routine analysis in pharmaceutical industries where large
numbers of samples are to be analyzed on a single day to fulﬁl the
healthcare requirements. Both the methods should be used in
parallel to obtain more realistic and precise measurement of po-
tency of antibiotics.References
[1] N.A. Dafale, U.P. Semwal, P.K. Agarwal, et al., Quantiﬁcation of ceftriaxone
sodium in pharmaceutical preparations by new validated microbiological
bioassay, Anal. Methods 4 (2012) 2490–2498.
[2] S.P. Denyer, N.A. Hodges, S.P. Gorman, Hugo & Russell’s Pharmaceutical Mi-
crobiology, Seventh ed., Blackwell Publishing Company, UK, 2004.
[3] Y.Q. Liu, Y.Z. Zhang, P.J. Gao, Novel concentration-killing curve method for
estimation of bactericidal potency of antibiotics in an in vitro dynamic model,
Antimicrob. Agents Chemother. 48 (2004) 3884–3891.
[4] N.A. Dafale, U.P. Semwal, P.K. Agarwal, et al., Development and validation of
microbial bioassay for quantiﬁcation of levoﬂoxacin in pharmaceutical pre-
parations, J. Pharm. Anal. 5 (2015) 18–26.
[5] L.M. Prescott, J.P. Harley, D.A. Klein, Microbiology, Seventh ed., Mcgraw-Hill,
New York 2008, pp. 835–858.
[6] E. Branson, Clinical relevance of minimum inhibitory concentration, Aqua-
culture 11 (2001) 289–296.
[7] U.C. Ejikeme, O.J. Ademola, Microbiological assay of the active component of
ampicillin in ampicillin and ampicillin/cloxacillin suspensions using Bacillus
megatharium NCTC 10342A (76) as indicator organism, Afr. J. Microbiol. Res. 4
(2010) 51–54.
[8] W. Hewitt, Microbiological Assay: An Introduction to Qualitative Principles
and Evaluation, First ed., Academic Press, New York 1977, pp. 1–50.
[9] A.F. Zuluaga, M. Agudelo, C.A. Rodriguez, etal., Application of microbiological
assay to determine pharmaceutical equivalence of generic intravenous anti-
biotics, BMC Clin. Pharmacol. 2009, http://dx.doi.org/10.1186/1472-6904-9-1.
[10] M.A. Pfaller, D.J. Krogstad, G.G. Granich, et al., Laboratory evaluation of ﬁve
assay methods for vancomycin: bioassay, high-pressure liquid chromato-
graphy, ﬂuorescence polarization immunoassay, radioimmunoassay, and
ﬂuorescence immunoassay, J. Clin. Microbiol. 20 (1984) 311–316.
[11] G.M. Greco, Microbiological Assay Systems for the Analysis of Antibiotics in
Pharmaceutical Formulations (PhD. Dissertation), The State University Of New
Jersey, USA, 1997.[12] T.J.A. Pinto, F.R. Lourenco, T.M. Kaneko, Microbiological assay of gentamycin
employing an alternative experimental design, AOAC Annual Meeting and
Exposition, Anais. Anahein-California, 2007, pp. 157.
[13] A.M. Saviano, F.L. Francisco, F.R. Lourenco, Rational development and valida-
tion of a new microbiological assay for linezolid and its measurement un-
certainty, Talanta 127 (2014) 225–229.
[14] N.A. Dafale, P.K. Agarwal, U.P. Semwal, et al., Development and validation of
microbial bioassay for the quantiﬁcation of potency of the antibiotic cefur-
oxime axetil, Anal. Methods 5 (2013) 690–698.
[15] E.C.L. Cazedey, H.R.N. Salgado, Development and validation of a micro-
biological agar assay for determination of orbiﬂoxacin in pharmaceutical
preparations, Pharmaceutics 3 (2011) 572–581.
[16] A.A. Abdelaziz, T.E. Elbanna, N.M. Gamaleldeen, Validated microbiological and
HPLC methods for the determination of moxiﬂoxacin in pharmaceutical pre-
parations and human plasma, Braz. J. Microbiol. (2012) 1291–1301.
[17] United States Pharmacopoeia, United States Pharmacopoeial Convention,
Rockville, MD, U.S.A, 2009, pp. 86–93.
[18] N. Dafale, L. Agrawal, A. Kapley, et al., Selection of indicator bacteria based on
screening of 16S rDNA metagenomic library from a two-stage anoxic–oxic
bioreactor system degrading azo dyes, Bioresour. Technol. 101 (2010) 476–484.
[19] N.A. Dafale, Exploration of genetic information from dynamic microbial po-
pulations for enhancing the efﬁciency of azo-dye-degrading systems, Environ.
Rev. 19 (2011) 310–332.
[20] C.H. Yamamoto, T.J.A. Pinto, Rapid determination of neomycin by a micro-
biological agar diffusion assay using triphenyltetrazolium chloride, J. Assoc.
Anal. Chem. 79 (1996) 434–440.
[21] F.R. Lourenco, T.J.A. Pinto, Comparison of three experimental designs em-
ployed in gentamycin microbiological assay through agar diffusion, Braz. J.
Pharm. Sci. 45 (2009) 559–566.
[22] J.G. Black, Microbiology: Principles and Explorations, Sixth ed., John Wiley &
Sons Inc., USA, 2005, pp. 352–384.
[23] Indian Pharmacopoeia, Indian Pharmacopoeia Commission, Ghaziabad, India,
2014, pp. 50–59.
[24] British Pharmacopoeia, The Stationary Ofﬁce, London, 2015, pp. V396V402.
[25] Farmacopeia Brasileira. Fourth ed., Sao Paulo, Atheneu, 1988, pt. 1, pp. V.5.2.17–
V.5.2.17-15.
[26] F.K. Hurtado, M.J. Souza, J.D. Melo, et al., Microbiological assay and HPLC
method for the determination of Fluconazole in pharmaceutical injectable
formulations, Lat. Am. J. Pharm. 27 (2008) 224–228.
[27] K.M. Queiroz, M.L.M. Silva, N.D. Prado, et al., Comparison of microbiological
assay and HPLC–UV for determination of ﬂuconazole in capsules, Braz. J.
Pharm. Sci. 45 (2009) 693–700.
[28] H.J. Simon, E.J. Yin, Microbial bioassay of antimicrobial agent, Antimicrob.
Agents Chemother. 19 (1970) 167–171.
[29] J.M. Andrews, Determination of minimum inhibitory concentration, J. Anti-
microb. Chemother. 48 (2001) 5–16.
[30] D. Sevillano, A. Calvo, M. Jose, et al., Bactericidal activity of amoxicillin against
non-susceptible Streptococcus pneumoniae in an in vitro pharmacodynamic
model simulating the concentrations obtained with the 2000/125 mg sus-
tained-release co-amoxiclav formulation, J. Antimicrob. Chemother. 54 (2004)
1148–1151.
[31] L. Struillou, Y. Cohen, N. Lounis, et al., Activities of roxithromycin against
N.A. Dafale et al. / Journal of Pharmaceutical Analysis 6 (2016) 207–213 213Mycobacterium avium infections in human macrophages and C57bl/6 MIC,
Antimicrob. Agents Chemother. 39 (1995) 878–881.
[32] Y.C. Hsieh, K.Y. Chang, Y.C. Huang, et al., Clonal spread of highly-lactam-re-
sistant Streptococcus pneumoniae isolates in Taiwan, Antimicrob. Agents Che-
mother. 52 (2008) 2266–2269.
[33] R. Jagannathan, P.R. Mahadevan, Minimum inhibitory concentration of drugs
against Mycobacterium leprae as determined by an in vitro assay, J. Biosci. 10
(1986) 137–144.
[34] R. Guna, C. Munoz, V. Dominguez, et al., In-vitro activity of linezolid, clari-
thromysin and moxiﬂoxacin against clinical isolates of Mycobacterium kansaii,
J. Antimicrob. Chemother. 55 (2005) 950–953.
[35] D. Landman, D. Bratu, M. Alam, et al., Citywide emergence of Pseudomonas
aeruginosa strains with reduced susceptibility to polymyxin B, J. Antimicrob.
Chemother. 55 (2005) 954–957.
[36] P. Jureen, K.A. Ngeby, E. Sturegard, et al., Wild-type MIC distributions for
amino glycoside and cyclic polypeptide antibiotics used for treatment of
Mycobacterium tuberculosis infections, J. Clin. Microbiol. 48 (2010) 1853–1858.
[37] T.R. Shryock, D.W. White, J.M.S. Taples, et al., Minimum inhibitory con-
centration breakpoints and disk diffusion inhibitory zone interpretive criteria
for tilmicosin susceptibility testing against Pasteurella species associated with
bovine respiratory disease, J. Vet. Diagn. Investig. 8 (1996) 37–44.
[38] B. Bonev, J. Hooper, J. Parisot, Principles of assessing bacterial susceptibility to
antibiotics using the agar diffusion method, J. Antimicrob. Chemother. 61
(2008) 1295–1301.
[39] E. Silva, J.A. Diaz, M.J. Arias, et al., Comparative in-vitro study of the anti-
microbial activities of different commercial antibiotic products for intravenous
administration, BMC Clin. Pharmacol. 10 (2010) 3.
[40] G.V. Doern, Antimicrobial use and the emergence of antimicrobial resistance
with Streptococcus pneumoniae in the United States, Clin. Infect. Dis. 33
(2001) S187–S192.
[41] Y. Dong, X. Zhao, J. Domagala, et al., Effect of ﬂuoroquinolones concentration
on selection of resistant mutants of Mycobacterium bovis BCG and Staphylo-
coccus aureus, Antimicrob. Agents Chemother. 43 (1999) 1756–1758.
[42] Y. Dong, X. Zhao, B.N. Kreiswirth, et al., Mutant prevention concentration as a
measure of antibiotic Potency: studies with clinical isolates of Mycobacterium
tuberculosis, Antimicrob. Agents Chemother. 44 (2000) 2581–2584.
[43] F. Pasquali, G. Manfreda, Mutant prevention concentration of ciproﬂoxacin
and enroﬂoxacin against Escherichia coli, Salmonella typhimurium and Pseu-
domonas aeruginosa, Vet. Microbiol. 119 (2007) 304–310.
[44] J.C. Roderfguez, L. Cebrian, M. Lopez, et al., Mutant prevention concentration:
a new tool for choosing treatment in nontuberculous Mycobacterial infections,
J. Antimicrob. Chemother. 24 (2004) 352–356.
[45] X. Zhao, C. Xu, J. Domagala, et al., DNA topoisomerase targets of the ﬂuor-
oquinolones: A strategy for avoiding bacterial resistance, Proc. Natl. Acad. Sci.
U.S.A. 94 (1997) 13991–13996.
[46] J. Blondeau, X. Zhao, G. Hansen, et al., Mutant prevention concentration (MPC)
as a guide for treating Streptococcus pneumoniae with ﬂuoroquinolones, An-
timicrob. Agents Chemother. 45 (2001) 433–438.
[47] H.B. Drugeon, M.E. Juvin, J. Caillon, et al., Assessment of formulas for calcu-
lating critical concentration by the agar diffusion method, Antimicrob. Agents
Chemother. 31 (1987) 870–875.
[48] W.W. Davis, T.R. Stout, Disc plate method of microbiological antibiotic assay
factors inﬂuencing variability and error-1, Appl. Microbiol. 22 (1971) 659–665.
[49] W.W. Davis, T.R. Stout, Disc plate method of microbiological antibiotic assayfactors inﬂuencing variability and error-2, Antimicrob. Agents Chemother. 10
(1971) 447–450.
[50] O. McPolin, An Introduction to HPLC for Pharmaceutical Analysis, Mourne
Training Services, Northern Ireland, UK, 2009.
[51] F. Lotﬁpour, H. Valizadeh, S.H. Nezhadi, et al., Comparison of microbiological
and high-performance liquid chromatographic methods for determination of
clarithromycin levels in plasma, Iran. J. Pharm. Res. 9 (2010) 27–35.
[52] G.M. Auten, L.C. Preheim, M. Sookpranee, et al., High-pressure liquid chro-
matography and microbiological assay of serum oﬂoxacin levels in adults re-
ceiving intravenous and oral therapy for skin infections, Antimicrob. Agents
Chemother. 35 (1991) 2558–2561.
[53] L. Li, M.V. Miles, W. Hall, et al., An improved micromethod for vancomycin
determination by high-performance liquid chromatography, Ther. Drug Monit.
17 (1995) 366–370.
[54] G.J. Pennick, S. Perea, A. Modak, et al., Comparison of high-performance liquid
chromatographic and microbiological methods for determination of vor-
iconazole levels in plasma, Antimicrob. Agents Chemother. 44 (2000)
1209–1213.
[55] S. Bottcher, B.H. Von, T. Hoppe-Tichy, et al., An HPLC assay and a micro-
biological assay to determine levoﬂoxacin in soft tissue, bone, bile and serum,
J. Pharm. Biomed. Anal. 25 (2001) 197–203.
[56] H.M. Brogard, L.F. Jehl, H. Monteil, et al., Comparison of high-pressure liquid
chromatography and microbiological assay for the determination of biliary
elimination of ciproﬂoxacin in body ﬂuids, Antimicrob. Agents Chemother. 28
(1985) 311–314.
[57] W. Hewitt, Microbiological Assay for Pharmaceutical Analysis: A Rational
Approach, CRC Press, Llandysul, UK, 2003, pp. 1–260.
[58] J.H. Rex, H. Hanson, M.A. Amantea, et al., Standardization of a ﬂuconazole
bioassay and correlation of results with those obtained by high-pressure li-
quid chromatography, Antimicrob. Agents Chemother. 35 (1991) 846–850.
[59] H.R.N. Salgado, C.O. Lopes, M.B.B. Lucchesi, Microbiological assay for gati-
ﬂoxacin in pharmaceutical formulations, J. Pharm. Biomed. Anal. 40 (2006)
443–446.
[60] H.R. Salgado, G.C. Tozo, Microbiological assay for cefoxitin sodium in dosage
form, J. Assoc. Anal. Chem. 90 (2007) 452–455.
[61] R.E. Bawdon, L. David, D.L. Hemsell, et al., Comparison of cefoperazone and
cefoxitin concentrations in serum and pelvic tissue of abdominal hyster-
ectomy patients, Antimicrob. Agents Chemother. 22 (1982) 999–1003.
[62] Y.A. Hekster, A.M. Baars, T.B. Vree, Comparison of high performance liquid
chromatography and microbiological assay in the determination of plasma
cefuroxime concentrations in rabbits, J. Antimicrob. Chemother. 6 (1980)
65–71.
[63] M.C. Hsu, P.W. Hsu, High-performance liquid chromatographic method for
potency determination of amoxicillin in commercial preparations and for
stability studies, Antimicrob. Agents Chemother. 36 (1992) 1276–1279.
[64] J. Sunderland, C.M. Tobin, A.J. Hedges, et al., Antimicrobial activity of ﬂuor-
oquinolone photodegradation products determined by parallel-line bioassay
and high performance liquid chromatography, J. Antimicrob. Chemother. 47
(2001) 271–275.
[65] N. Patel, P. Lubanski, S. Ferro, et al., Correlation between vancomysin MIC
values and those of other agents against gram positive bacteria among pa-
tients with blood stream infections caused by methicillin-resistant Staphylo-
coccus aureus, Antimicrob. Agents Chemother. 53 (2009) 5141–5144.
